Commercial
Advanced Search
  
MPNewsFlashTopicPub
MPPurposePub
  
  
  
  
2/12/2024
Coverage of the COVID-19 Vaccination for Independence Commercial Members (Updated February 12, 2024. Retroactively Effective to January 1, 2024.)

This communication provides notice regarding information and procedure codes related to the coverage of SARS-CoV-2 (Coronavirus Disease 2019 [COVID-19]) vaccines and administration of the vaccines​ that have been granted US Food and Drug Administration (FDA) approval and/or have received an Emergency Use Authorization (EUA). Coverage of SARS-CoV-2 (Coronavirus Disease 2019 [COVID-19]) vaccines granted an EUA shall remain in effect during the applicable EUA declaration, unless the specific EUA for a SARS-CoV-2 vaccine​ has been terminated and/or revoked. 

0.1Coverage of the COVID-19 Vaccination for Independence Commercial Members (Updated February 12, 2024. Retroactively Effective to January 1, 2024.)1085387c-a745-4a07-8a69-2290d8c3ef5b
12/29/2023
1/01/2024 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 01/01/2024, unless otherwise noted. For more information related to these services, please refer to specific policies when applicable.​​​​​​​
0.11/01/2024 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products909de290-c38e-482a-8045-e2b79aa51749
12/15/2023
Coverage of Meningococcal ABCWY vaccine and Smallpox and Mpox Vaccine for Independence Commercial Members (Retroactively Effective to October 26, 2023)
Retroactively effective to October 26, 2023, the purpose of this communication is to provide notice regarding the coverage criteria for meningococcal groups A, B, C, W, and Y vaccine (Penbraya) and smallpox and mpox vaccine, live, non-replicating (Jynneos) vaccine for Independence Commercial members.
0.1Coverage of Meningococcal ABCWY vaccine and Smallpox and Mpox Vaccine for Independence Commercial Members (Retroactively Effective to October 26, 2023)4d83d901-88bb-4142-bd8d-fd6db9a7fafd
10/16/2023
Coverage of Respiratory Syncytial Virus Immunizations for Independence Commercial Members (Updated October 16, 2023; Retroactively Effective October 6, 2023)
The purpose of this communication is to provide notice regarding the coverage criteria for respiratory syncytial virus (RSV) immunization for Independence Commercial members. ​

Thi​s​ policy communication, addressing RSV immunization for Independence Commercial members, replaces the version that was published on September 28, 2023, and includes the following updates: 
  • Retroactively effective to October 6, 2023, the following codes were added as eligible as preventive: 96380, 96381​


0.1Coverage of Respiratory Syncytial Virus Immunizations for Independence Commercial Members (Updated October 16, 2023; Retroactively Effective October 6, 2023)cf62e057-0ad2-462b-840a-99608ec3085f
10/10/2023
Expanded Coverage of 20-Valent Pneumococcal Conjugate Vaccine for Independence Commercial Members (Retroactively Effective June 27, 2023)
Retroactively effective to June 27, 2023, the purpose of this communication is to provide notice regarding the expanded ​preventive coverage criteria for 20-valent p​neumococcal conjugate vaccine for Independence Commercial members. ​
0.1Expanded Coverage of 20-Valent Pneumococcal Conjugate Vaccine for Independence Commercial Members (Retroactively Effective June 27, 2023)d42263c4-4539-478c-b7b2-c1609c14d68f
5/12/2023
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated May 12, 2023)

The purpose of this communication is to provide notice regarding information and procedure codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence commercial members. Additionally, this Company document identifies when coverage is provided for clinical purposes, and the nonco​vered instances such as public health surveillance and screening. 




0.1Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated May 12, 2023)89689bbb-5b37-4282-b90a-69b3d315792d
1/4/2021
1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Annual Code Update process. 
01/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Productsb976b7b6-ff87-4f04-a559-d2f8805e0586
4/29/2020
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)
The purpose of this News Article is to provide advance notice regarding direct supervision requirements for Incident to services performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in response to Coronavirus Disease 2019 (COVID-19).
1Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)CC0B8A7BBD74419185258558007CCF61